Literature DB >> 9462605

Free fatty acid kinetics and oxidation in congestive heart failure.

J Lommi1, M Kupari, H Yki-Järvinen.   

Abstract

To characterize fuel utilization of patients with congestive heart failure (CHF), we measured serum free fatty acid (FFA), counterregulatory hormone concentrations, whole body substrate oxidation rates (indirect calorimetry), and the turnover and oxidation rates of FFA ([1-(14)C]-palmitate infusion) in 7 patients with CHF and in 7 cardiac patients without CHF after an overnight fast. Plasma glucose and serum insulin concentrations were comparable, whereas serum FFA, blood ketone body, and fasting blood lactate (p <0.05 for all) concentrations were significantly increased in patients with CHF compared to those without CHF. Fasting plasma norepinephrine (p <0.05), serum cortisol (p <0.01), and growth hormone (p <0.01) concentrations were also higher in patients with CHF than in those without CHF. Rates of energy expenditure at rest (62 +/- 2 vs 56 +/- 1 J x kg(-1) x min(-1), p <0.05), FFA turnover (6.5 +/- 0.5 vs 5.0 +/- 0.4 micromol x kg(-1) x min(-1), p <0.05), and oxidation (2.0 +/- 0.2 vs 1.5 +/- 0.1 micromol x kg(-1) x min(-1)], p <0.05) were significantly higher in patients with CHF than in control subjects. In univariate analysis, the left ventricular ejection fraction was inversely correlated and the plasma norepinephrine concentration positively correlated with both energy expenditure at rest, FFA turnover, and the FFA oxidation rate. In multivariate analysis, the plasma norepinephrine concentration was the most significant predictor of increased FFA oxidation rate. We conclude that release of FFAs to the circulation and their subsequent oxidation are increased in patients with severe CHF after an overnight fast. These changes might reflect stress hormone-induced lipolysis and accompanying stimulation of serum FFA oxidation via mass action.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9462605     DOI: 10.1016/s0002-9149(97)00804-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  36 in total

1.  G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia.

Authors:  Michele Ciccarelli; J Kurt Chuprun; Giuseppe Rengo; Erhe Gao; Zhengyu Wei; Raymond J Peroutka; Jessica I Gold; Anna Gumpert; Mai Chen; Nicholas J Otis; Gerald W Dorn; Bruno Trimarco; Guido Iaccarino; Walter J Koch
Journal:  Circulation       Date:  2011-04-25       Impact factor: 29.690

2.  Metabolomic analysis of pressure-overloaded and infarcted mouse hearts.

Authors:  Brian E Sansbury; Angelica M DeMartino; Zhengzhi Xie; Alan C Brooks; Robert E Brainard; Lewis J Watson; Andrew P DeFilippis; Timothy D Cummins; Matthew A Harbeson; Kenneth R Brittian; Sumanth D Prabhu; Aruni Bhatnagar; Steven P Jones; Bradford G Hill
Journal:  Circ Heart Fail       Date:  2014-04-24       Impact factor: 8.790

3.  Ketone bodies disturb fatty acid handling in isolated cardiomyocytes derived from control and diabetic rats.

Authors:  Danny M Hasselbaink; Jan F C Glatz; Joost J F P Luiken; Theo H M Roemen; Ger J Van der Vusse
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

Review 4.  Modulating fatty acid oxidation in heart failure.

Authors:  Vincenzo Lionetti; William C Stanley; Fabio A Recchia
Journal:  Cardiovasc Res       Date:  2011-02-02       Impact factor: 10.787

Review 5.  Fatty heart, cardiac damage, and inflammation.

Authors:  Maria A Guzzardi; Patricia Iozzo
Journal:  Rev Diabet Stud       Date:  2011-11-10

Review 6.  Mitochondrial remodeling: Rearranging, recycling, and reprogramming.

Authors:  Roberta A Gottlieb; Daniel Bernstein
Journal:  Cell Calcium       Date:  2016-04-20       Impact factor: 6.817

7.  Nicotinamide mononucleotide requires SIRT3 to improve cardiac function and bioenergetics in a Friedreich's ataxia cardiomyopathy model.

Authors:  Angelical S Martin; Dennis M Abraham; Kathleen A Hershberger; Dhaval P Bhatt; Lan Mao; Huaxia Cui; Juan Liu; Xiaojing Liu; Michael J Muehlbauer; Paul A Grimsrud; Jason W Locasale; R Mark Payne; Matthew D Hirschey
Journal:  JCI Insight       Date:  2017-07-20

Review 8.  Adipose tissue biology and cardiomyopathy: translational implications.

Authors:  Aslan T Turer; Joseph A Hill; Joel K Elmquist; Philipp E Scherer
Journal:  Circ Res       Date:  2012-12-07       Impact factor: 17.367

9.  Assessment of metabolic phenotypes in patients with non-ischemic dilated cardiomyopathy undergoing cardiac resynchronization therapy.

Authors:  Sebastian Obrzut; Jay Tiongson; Neema Jamshidi; Huy Minh Phan; Carl Hoh; Ulrika Birgersdotter-Green
Journal:  J Cardiovasc Transl Res       Date:  2010-09-15       Impact factor: 4.132

10.  Myocardial glucose and lactate metabolism during rest and atrial pacing in humans.

Authors:  Bryan C Bergman; Tatiana Tsvetkova; Brian Lowes; Eugene E Wolfel
Journal:  J Physiol       Date:  2009-03-16       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.